MarketPeel
Insider Trading Intelligence
Pricing
…
VL

Vivo Capital Surplus Fund Viii, L.p.

TERN
10% OWNER · TERNS PHARMACEUTICALS, INC. · CIK 0001628048
FILING MIX · LIFETIME30%/70%
BUYS
33
SELLS
76
TOTAL VALUE
$55.02M
COMPANIES
4
ACTIVE SINCE
Jan 2020
HOLDINGS NOW
6,661,629
AVG SELL PX
$11.17
TRADE KIND
SHOWING 109 / 109
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
59 backtested trades · 8 horizons
Forward-return performance of every backtestable P/S trade by Vivo Capital Surplus Fund Viii, L.p., measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d59+38.98%+0.55%+0.30%+0.25%-1.51%0.12
14d59+35.59%-1.33%-0.49%-0.84%-0.74%-0.40
30d59+71.19%+5.10%-2.54%+7.64%+4.93%2.49
60d59+59.32%+0.84%-2.61%+3.45%-11.13%0.83
90d59+61.02%+3.14%+2.97%+0.17%-8.30%0.04
180d59+59.32%+5.91%+11.88%-5.97%-25.72%-0.83
1y59+74.58%-22.85%+25.21%-48.06%-50.37%-10.67
2y59+50.85%+103.43%+41.82%+61.61%-55.99%1.76
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
TERN · 4,023,741 shares · as of Apr 3, 2024
01,085,0532,170,1063,255,1594,340,212202220232024SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2020
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
FLOW · 33 buys / 76 sellsCOVERAGE · 18 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
TERN
TERNS PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
4,149$6.20$25.7K268,573Apr 3, 2024Apr 3, 2024 ↗View →
TERN
TERNS PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
30,047$6.20$186.3K1,945,015Apr 3, 2024Apr 3, 2024 ↗View →
TERN
TERNS PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
103,870$6.20$644.0K4,023,741Apr 3, 2024Apr 3, 2024 ↗View →
TERN
TERNS PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
22,084$6.65$146.9K1,975,062Apr 2, 2024Apr 3, 2024 ↗View →
TERN
TERNS PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
76,346$6.65$507.7K4,127,611Apr 2, 2024Apr 3, 2024 ↗View →
TERN
TERNS PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
3,050$6.65$20.3K272,722Apr 2, 2024Apr 3, 2024 ↗View →
TERN
TERNS PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
39,411$6.99$275.5K1,997,146Apr 1, 2024Apr 3, 2024 ↗View →
TERN
TERNS PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
136,255$6.99$952.4K4,203,957Apr 1, 2024Apr 3, 2024 ↗View →
TERN
TERNS PHARMACEUTICALS, INC.
SALE10b5-1
10b5-1 plan
5,451$6.99$38.1K275,772Apr 1, 2024Apr 3, 2024 ↗View →
BOLT
BOLT BIOTHERAPEUTICS, INC.
SALE
236$0.90$212269,587Nov 21, 2023Nov 22, 2023 ↗View →
BOLT
BOLT BIOTHERAPEUTICS, INC.
SALE
1,707$0.90$1.5K1,952,302Nov 21, 2023Nov 22, 2023 ↗View →
BOLT
BOLT BIOTHERAPEUTICS, INC.
SALE
1,457$0.90$1.3K111,662Nov 21, 2023Nov 22, 2023 ↗View →
BOLT
BOLT BIOTHERAPEUTICS, INC.
SALE
27,465$0.92$25.3K1,954,009Nov 20, 2023Nov 20, 2023 ↗View →
BOLT
BOLT BIOTHERAPEUTICS, INC.
SALE
3,792$0.92$3.5K269,823Nov 20, 2023Nov 20, 2023 ↗View →
BOLT
BOLT BIOTHERAPEUTICS, INC.
SALE
23,443$0.92$21.6K113,119Nov 20, 2023Nov 20, 2023 ↗View →
BOLT
BOLT BIOTHERAPEUTICS, INC.
SALE
1,134$0.93$1.1K273,615Nov 17, 2023Nov 20, 2023 ↗View →
BOLT
BOLT BIOTHERAPEUTICS, INC.
SALE
8,211$0.93$7.6K1,981,474Nov 17, 2023Nov 20, 2023 ↗View →
BOLT
BOLT BIOTHERAPEUTICS, INC.
SALE
7,009$0.93$6.5K136,562Nov 17, 2023Nov 20, 2023 ↗View →
BOLT
BOLT BIOTHERAPEUTICS, INC.
SALE
7,531$0.96$7.2K1,989,685Nov 16, 2023Nov 20, 2023 ↗View →
BOLT
BOLT BIOTHERAPEUTICS, INC.
SALE
1,040$0.96$998274,749Nov 16, 2023Nov 20, 2023 ↗View →
BOLT
BOLT BIOTHERAPEUTICS, INC.
SALE
6,429$0.96$6.2K143,571Nov 16, 2023Nov 20, 2023 ↗View →
TERN
TERNS PHARMACEUTICALS, INC.
PURCHASE
758,620$7.25$5.50M4,340,212Dec 23, 2022Dec 23, 2022 ↗View →
TERN
TERNS PHARMACEUTICALS, INC.
PURCHASE
600,000$3.60$2.16M3,581,592Sep 7, 2022Sep 8, 2022 ↗View →
TERN
TERNS PHARMACEUTICALS, INC.
PURCHASE
1,500,000$2.42$3.63M2,981,592Aug 16, 2022Aug 16, 2022 ↗View →
TERN
TERNS PHARMACEUTICALS, INC.
PURCHASE
1,500,000$2.42$3.63M1,500,000Aug 16, 2022Aug 16, 2022 ↗View →
TERN
TERNS PHARMACEUTICALS, INC.
PURCHASE
1,218$2.99$3.6K1,481,592Aug 15, 2022Aug 16, 2022 ↗View →
TERN
TERNS PHARMACEUTICALS, INC.
PURCHASE
1,123,021$2.98$3.35M1,480,374Aug 12, 2022Aug 16, 2022 ↗View →
BOLT
BOLT BIOTHERAPEUTICS, INC.
PURCHASE
944,056——958,341Feb 9, 2021Feb 9, 2021 ↗View →
BOLT
BOLT BIOTHERAPEUTICS, INC.
SALE
144$20.00$2.9K1,821,483Feb 9, 2021Feb 9, 2021 ↗View →
BOLT
BOLT BIOTHERAPEUTICS, INC.
SALE
17,711——0Feb 9, 2021Feb 9, 2021 ↗View →
BOLT
BOLT BIOTHERAPEUTICS, INC.
SALE
5,655——0Feb 9, 2021Feb 9, 2021 ↗View →
BOLT
BOLT BIOTHERAPEUTICS, INC.
SALE
20$20.00$400251,522Feb 9, 2021Feb 9, 2021 ↗View →
BOLT
BOLT BIOTHERAPEUTICS, INC.
PURCHASE
17,711$0.07$1.2K1,448,348Feb 9, 2021Feb 9, 2021 ↗View →
BOLT
BOLT BIOTHERAPEUTICS, INC.
PURCHASE
1,092,080——1,117,184Feb 9, 2021Feb 9, 2021 ↗View →
BOLT
BOLT BIOTHERAPEUTICS, INC.
SALE
150,802——0Feb 9, 2021Feb 9, 2021 ↗View →
BOLT
BOLT BIOTHERAPEUTICS, INC.
SALE
472,296——0Feb 9, 2021Feb 9, 2021 ↗View →
BOLT
BOLT BIOTHERAPEUTICS, INC.
PURCHASE
150,802——154,268Feb 9, 2021Feb 9, 2021 ↗View →
BOLT
BOLT BIOTHERAPEUTICS, INC.
PURCHASE
47,718——245,887Feb 9, 2021Feb 9, 2021 ↗View →
BOLT
BOLT BIOTHERAPEUTICS, INC.
PURCHASE
175,733$20.00$3.51M1,997,216Feb 9, 2021Feb 9, 2021 ↗View →
BOLT
BOLT BIOTHERAPEUTICS, INC.
SALE
1,092,080——0Feb 9, 2021Feb 9, 2021 ↗View →
BOLT
BOLT BIOTHERAPEUTICS, INC.
PURCHASE
317,922——1,435,106Feb 9, 2021Feb 9, 2021 ↗View →
BOLT
BOLT BIOTHERAPEUTICS, INC.
SALE
40,953——0Feb 9, 2021Feb 9, 2021 ↗View →
BOLT
BOLT BIOTHERAPEUTICS, INC.
PURCHASE
5,655$0.07$396251,542Feb 9, 2021Feb 9, 2021 ↗View →
BOLT
BOLT BIOTHERAPEUTICS, INC.
PURCHASE
24,267$20.00$485.3K275,789Feb 9, 2021Feb 9, 2021 ↗View →
BOLT
BOLT BIOTHERAPEUTICS, INC.
PURCHASE
43,901——198,169Feb 9, 2021Feb 9, 2021 ↗View →
BOLT
BOLT BIOTHERAPEUTICS, INC.
SALE
62$20.00$1.2K1,448,286Feb 9, 2021Feb 9, 2021 ↗View →
BOLT
BOLT BIOTHERAPEUTICS, INC.
PURCHASE
472,296——1,430,637Feb 9, 2021Feb 9, 2021 ↗View →
BOLT
BOLT BIOTHERAPEUTICS, INC.
PURCHASE
40,953$0.07$2.9K1,821,627Feb 9, 2021Feb 9, 2021 ↗View →
BOLT
BOLT BIOTHERAPEUTICS, INC.
PURCHASE
345,568——1,780,674Feb 9, 2021Feb 9, 2021 ↗View →
BOLT
BOLT BIOTHERAPEUTICS, INC.
SALE
43,901——0Feb 9, 2021Feb 9, 2021 ↗View →
BOLT
BOLT BIOTHERAPEUTICS, INC.
SALE
47,718——0Feb 9, 2021Feb 9, 2021 ↗View →
BOLT
BOLT BIOTHERAPEUTICS, INC.
SALE
345,568——0Feb 9, 2021Feb 9, 2021 ↗View →
BOLT
BOLT BIOTHERAPEUTICS, INC.
PURCHASE
150,000$20.00$3.00M150,000Feb 9, 2021Feb 9, 2021 ↗View →
BOLT
BOLT BIOTHERAPEUTICS, INC.
SALE
317,922——0Feb 9, 2021Feb 9, 2021 ↗View →
BOLT
BOLT BIOTHERAPEUTICS, INC.
SALE
944,056——0Feb 9, 2021Feb 9, 2021 ↗View →
TERN
TERNS PHARMACEUTICALS, INC.
SALE
50,282——0Feb 9, 2021Feb 9, 2021 ↗View →
TERN
TERNS PHARMACEUTICALS, INC.
SALE
98,484——0Feb 9, 2021Feb 9, 2021 ↗View →
TERN
TERNS PHARMACEUTICALS, INC.
PURCHASE
103,372$17.00$1.76M2,036,557Feb 9, 2021Feb 9, 2021 ↗View →
TERN
TERNS PHARMACEUTICALS, INC.
PURCHASE
266,948——266,948Feb 9, 2021Feb 9, 2021 ↗View →
TERN
TERNS PHARMACEUTICALS, INC.
SALE
364,138——0Feb 9, 2021Feb 9, 2021 ↗View →
TERN
TERNS PHARMACEUTICALS, INC.
PURCHASE
1,933,185——1,933,185Feb 9, 2021Feb 9, 2021 ↗View →
TERN
TERNS PHARMACEUTICALS, INC.
PURCHASE
357,353$17.00$6.08M357,353Feb 9, 2021Feb 9, 2021 ↗View →
TERN
TERNS PHARMACEUTICALS, INC.
PURCHASE
14,275$17.00$242.7K281,223Feb 9, 2021Feb 9, 2021 ↗View →
TERN
TERNS PHARMACEUTICALS, INC.
SALE
713,203——0Feb 9, 2021Feb 9, 2021 ↗View →
ALGS
ALIGOS THERAPEUTICS, INC.
PURCHASE
260,380——260,380Oct 20, 2020Oct 20, 2020 ↗View →
ALGS
ALIGOS THERAPEUTICS, INC.
SALE
523,726——0Oct 20, 2020Oct 20, 2020 ↗View →
ALGS
ALIGOS THERAPEUTICS, INC.
PURCHASE
66,733$15.00$1.00M430,372Oct 20, 2020Oct 20, 2020 ↗View →
ALGS
ALIGOS THERAPEUTICS, INC.
SALE
1,885,611——0Oct 20, 2020Oct 20, 2020 ↗View →
ALGS
ALIGOS THERAPEUTICS, INC.
PURCHASE
224,054——2,633,391Oct 20, 2020Oct 20, 2020 ↗View →
ALGS
ALIGOS THERAPEUTICS, INC.
SALE
30,939——0Oct 20, 2020Oct 20, 2020 ↗View →
ALGS
ALIGOS THERAPEUTICS, INC.
SALE
224,054——0Oct 20, 2020Oct 20, 2020 ↗View →
ALGS
ALIGOS THERAPEUTICS, INC.
SALE
260,380——0Oct 20, 2020Oct 20, 2020 ↗View →
ALGS
ALIGOS THERAPEUTICS, INC.
PURCHASE
483,267$15.00$7.25M3,116,658Oct 20, 2020Oct 20, 2020 ↗View →
ALGS
ALIGOS THERAPEUTICS, INC.
SALE
72,320——0Oct 20, 2020Oct 20, 2020 ↗View →
ALGS
ALIGOS THERAPEUTICS, INC.
PURCHASE
523,726——2,409,337Oct 20, 2020Oct 20, 2020 ↗View →
ALGS
ALIGOS THERAPEUTICS, INC.
PURCHASE
1,885,611——1,885,611Oct 20, 2020Oct 20, 2020 ↗View →
ALGS
ALIGOS THERAPEUTICS, INC.
PURCHASE
72,320——332,700Oct 20, 2020Oct 20, 2020 ↗View →
ALGS
ALIGOS THERAPEUTICS, INC.
PURCHASE
30,939——363,639Oct 20, 2020Oct 20, 2020 ↗View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
SALE
10,265$15.40$158.1K298,625Apr 17, 2020Apr 17, 2020 ↗View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
SALE
74,333$15.40$1.14M2,162,587Apr 17, 2020Apr 17, 2020 ↗View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
SALE
26,527$15.20$403.2K2,236,920Apr 16, 2020Apr 17, 2020 ↗View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
SALE
3,663$15.20$55.7K308,890Apr 16, 2020Apr 17, 2020 ↗View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
SALE
189,625$15.50$2.94M2,263,447Apr 15, 2020Apr 17, 2020 ↗View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
SALE
26,185$15.50$405.9K312,553Apr 15, 2020Apr 17, 2020 ↗View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
SALE
5,373$14.20$76.3K2,453,072Apr 7, 2020Apr 7, 2020 ↗View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
SALE
742$14.20$10.5K338,738Apr 7, 2020Apr 7, 2020 ↗View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
SALE
263,600$13.80$3.64M2,458,445Apr 3, 2020Apr 7, 2020 ↗View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
SALE
36,400$13.80$502.3K339,480Apr 3, 2020Apr 7, 2020 ↗View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
SALE
347$19.50$6.8K2,722,045Mar 9, 2020Mar 11, 2020 ↗View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
SALE
48$19.50$936375,880Mar 9, 2020Mar 11, 2020 ↗View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
SALE
133$19.50$2.6K168,165Mar 9, 2020Mar 11, 2020 ↗View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
SALE
200$21.40$4.3K375,928Feb 10, 2020Feb 11, 2020 ↗View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
SALE
5,904$21.40$126.3K168,298Feb 10, 2020Feb 11, 2020 ↗View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
SALE
1,451$21.40$31.1K2,722,392Feb 10, 2020Feb 11, 2020 ↗View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
SALE
4,614$22.00$101.5K174,202Feb 7, 2020Feb 11, 2020 ↗View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
SALE
1,134$22.00$24.9K2,723,843Feb 7, 2020Feb 11, 2020 ↗View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
SALE
157$22.00$3.5K376,128Feb 7, 2020Feb 11, 2020 ↗View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
SALE
10,519$22.80$239.8K178,816Feb 4, 2020Feb 6, 2020 ↗View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
SALE
2,584$22.80$58.9K2,724,977Feb 4, 2020Feb 6, 2020 ↗View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
SALE
357$22.80$8.1K376,285Feb 4, 2020Feb 6, 2020 ↗View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
SALE
1,037$21.70$22.5K2,727,561Jan 31, 2020Jan 31, 2020 ↗View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
SALE
143$21.70$3.1K376,642Jan 31, 2020Jan 31, 2020 ↗View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
SALE
4,220$21.70$91.6K189,335Jan 31, 2020Jan 31, 2020 ↗View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
SALE
5,940$22.10$131.3K193,555Jan 30, 2020Jan 31, 2020 ↗View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
SALE
1,459$22.10$32.2K2,728,598Jan 30, 2020Jan 31, 2020 ↗View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
SALE
201$22.10$4.4K376,785Jan 30, 2020Jan 31, 2020 ↗View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
SALE
10,878$22.20$241.5K199,495Jan 29, 2020Jan 31, 2020 ↗View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
SALE
369$22.20$8.2K376,986Jan 29, 2020Jan 31, 2020 ↗View →
CRNX
CRINETICS PHARMACEUTICALS, INC.
SALE
2,673$22.20$59.3K2,730,057Jan 29, 2020Jan 31, 2020 ↗View →
Other insiders · TERN
Loading peer insiders…
About this filer
CIK 0001628048
ROLE
10% Owner
PRIMARY
TERN
COMPANIES
4
ACTIVE SINCE
Jan 2020
MARKETPEEL · /INSIDER/0001628048DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback